{"id":726152,"date":"2023-01-26T08:34:47","date_gmt":"2023-01-26T13:34:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/"},"modified":"2023-01-26T08:34:47","modified_gmt":"2023-01-26T13:34:47","slug":"artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/","title":{"rendered":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>CEO Gregory Gorgas to discuss developments related to the Company\u2019s\u00a0<\/em><br \/>\n        <em>Cancer Appetite Recovery Study (CAReS)<\/em>\n      <\/p>\n<p align=\"center\">\n        <em>Presentation on Thursday, February 2, 2023 at 1:00 PM ET<\/em>\n      <\/p>\n<p>SOLANA BEACH, Calif., Jan.  26, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E6wSfoT7lE231SvDmdH2K2bCS0MuhlECKD6Lzte788xq78hRTIa0qsCOQyO0B8eaiSs6iQS1-4p4Lug31vskAkEts623dQEwHynct1Bux6qaQ2svpRre1A_Vo2gyNh1WUjaeGtISjuRzEdeQppi7yKZdsc7FAqFqk3G0TPZawITnSvNWiAxRvrsT9OEljZuHbyAMCepMeAfqU3Fve3VFzg__z3eB-6GX6ueQhIpCMYtIgef2dTYyslKC5j1gz1RqiIgJJKW73awgMcoAxGG4wg==\" rel=\"nofollow noopener\" target=\"_blank\">Artelo Biosciences, Inc.<\/a>\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, announced today that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting virtually at the Sequire Biotechnology Conference. Mr. Gorgas plans to discuss the latest developments related to the Company\u2019s ongoing Cancer Appetite Recovery Study (CAReS).<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:100%;width:100%;min-width:100%\">\n            <strong>Presentation details:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Event:<\/strong> Artelo\u2019s Presentation at the Sequire Biotechnology Conference<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Date:<\/strong> Thursday, February 2, 2023<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt\">\n            <strong>Time:<\/strong> 1:00 PM Eastern Time<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">Register to watch the presentation at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KHEg1d1YDT_OP4uqKdnQVb-3v8O0c8PX0RAASR-kbKdEjwvGphLvkrOV7LCvJ8NzPukPFfWXUjNCOTYaGwiOLRFJ9TIFofxekD25_8nGcj7vmGhW0hEhjA5b5nhhrw-0\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/biotech.sequireevents.com\/<\/a>.\u00a0<\/p>\n<p>\n        <strong>Summary of Sequire Biotechnology Conference<\/strong>\n      <\/p>\n<p>Expected to reach over $727 billion by 2025, the Biotechnology industry is showing consistent growth with over 6,500 biotech companies within the US and over 20,000 worldwide This one-day virtual investor event, highlighting public companies in the biotechnology space, will be held via SRAX\u2019s Sequire Virtual Events platform. Thousands of active biotechnology investors have been invited to the event, which will feature several biotechnology focused companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in this space.\u00a0<\/p>\n<p>\n        <strong>About Artelo Biosciences<\/strong><br \/>\n        \n      <\/p>\n<p>Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions. Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven pharmaceutical executives collaborating with highly respected researchers and technology experts, Artelo applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QcaoMk_OrdTA46lXX1IjgMi8a1DmGiZZfTCp8furDFBmlt0m9mKH1oH2Td2joDsQupmO-isuK3QcV7vbFdT1GgAAO7ENT9H0TmeCrnWmcK6vDgCa2ZRBpqv5zMSw8EZ9VtJmEwMHo8dR_Ojs4AF4ArojMPd2Ommk3xRfKZhOT09ExWi3XHEeJJlcpcjJuw4zS81Wo3UUN-l22sM1de02RcolB_OixNFAbRAypHfleDpVupKzWm-Ha0xjC6obwy1B3sq9URs9_QoVlXhkXjfEc8RfD-7GXw22noINKoH1ABC0mrXPxV-3QSq4x5t0DelIqOeSCUziThEirwSJEBVQt_wjO10FWx0HEAIDSnb31tDzh0VMmencUJgyCaFi-sl0-e9PZkuy8CFToSBdvnpOEG3MAjY3Sl8EdarEUwacSvkD2AMI-N7AswcCJKbaXgKqiPpgT4SwDmARXuwNnmIt5CeEKpHh7Fz4ukqBaFAWz5nOjZ3SLLeVDcVunoY_OU2Hw1RDl5LCzw_b7o0CB6MQmv7nE3_ZRN1rqvFxDeLX-zVeBeb_C652xap4nA1o9wbKC5VXRjYe65dRRrrjS4IlSquhAfAmppVkcIaBA0chDw6iN3PDy6BASjXiUAGvNqYllN6sqiffyBX10mXwbjjnSBgeOJbfaEN7DB5JyLB72XOtSmVvEzMZO8UhwIoAcFpfRV0NuBNqJ1eLVc-TMXo3-1EEqG72HcHJicbtxpTofKxWsuNTMBf15JAYpegcvE-mSke1DC0IG0ExuBWMC4SwCUiu4EIMDyvmcPbBiVgEO48=\" rel=\"nofollow noopener\" target=\"_blank\">www.artelobio.com<\/a>\u00a0and Twitter:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WciXyVJZ3iHz9gZ3UfDiMu6_zGs5O_Gph3xu4_AH50ZSbhCzB_Kt0X8Har22wEOJDY_bcXHgPrycDWF23P_tzNHJw6Rvl3B4yqK6A-ivrAWnqwY-3A0UW_X4KlFiaEI8MEGZeI2VayDOK-EYgpk6UooekZLm8Amwc2qulv95zFqwqFOM1WuCUZ02i18qJcyFIwtliR_ynO3Oo-zaoGFpbFMtzI-QhRhPqXC7nHYM6R2Hw8qjsrzodahL1olb8KS2aao4LsfpeGX8FoiJ5uzBJVQMLwpGthx9dCbxh1LYamzt4aAw0cOWNpXGWKUhU5MLaWNYE_sVRMIPnx74E60RxtKQarpL61L84tGUUw6B8F0jLvZL4zAxQnuBwTKKkR02dHUuV_Cd_bfCVmAZdpy2auHyXSv13e_u2YQj8ak2Ff68e0iMIB6E80sd0QHCXlqbByCOFERrUkErOfGyBo7SDHtDV7ezWLaRaf8a0OgSxCzBqrJDoSDzcGlgXlUYj2M7LDXOMjl1OOgb4akk9dyZxv0LrP6RzjRkx9f9eyNvRxr7KpVKud4CafjC50e2gE4ODj6Z2Rt4y7NY_8ZYvAWOLeUKTEh7ZyRTVgig1fyIszyygQ5BS-a_kR5dq-IWe8xzSxnuvuh2BTCm_RL8fP0V1-fgHlf_hHjab0mz-2ygY3EKKZJOOxVUH9QpGrHaNXFr\" rel=\"nofollow noopener\" target=\"_blank\">@ArteloBio<\/a>.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to Artelo\u2019s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in Artelo\u2019s filings with the Securities and Exchange Commission, including our ability to raise additional capital in the future. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Artelo undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable securities laws.<\/em><br \/>\n        \n      <\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Crescendo Communications, LLC<br \/>Tel: 212-671-1020<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CPrTepK9zj13ejht7zSjC29ZQWfS6KN_BeVZxBziKlC-NPmkR6p_p7chfXawV1XBHLNvBRXiTIEL6elXmT9G36yojnRjyVWpFfQj-oFjWBMMzyjvS9N3o3TcMKPXR-Vel1E9d8ZLgRWUN4rROOSPdXYu_KDGjpbZRNR2fZQyH1E6ALg564BovpRD7Rc9n9rsKoG7J8OmBm25t0K6CeimOa0_XL2FKq3iUuzNWCOaSdbnPSWedv3GsT2mUxUD6s4vW4PQ_mbh4j-M6oozAI1UIQ==\" rel=\"nofollow noopener\" target=\"_blank\">ARTL@crescendo-ir.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTZkOTBhNmQtNDlkYS00YmEwLWE2OTYtOGY0Y2U2NzQxY2ZmLTExOTkxMjM=\/tiny\/Artelo-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CEO Gregory Gorgas to discuss developments related to the Company\u2019s\u00a0 Cancer Appetite Recovery Study (CAReS) Presentation on Thursday, February 2, 2023 at 1:00 PM ET SOLANA BEACH, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, announced today that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting virtually at the Sequire Biotechnology Conference. Mr. Gorgas plans to discuss the latest developments related to the Company\u2019s ongoing Cancer Appetite Recovery Study (CAReS). Presentation details: Event: Artelo\u2019s Presentation at the Sequire Biotechnology Conference Date: Thursday, February 2, 2023 Time: 1:00 PM Eastern Time Register to watch the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-726152","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CEO Gregory Gorgas to discuss developments related to the Company\u2019s\u00a0 Cancer Appetite Recovery Study (CAReS) Presentation on Thursday, February 2, 2023 at 1:00 PM ET SOLANA BEACH, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, announced today that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting virtually at the Sequire Biotechnology Conference. Mr. Gorgas plans to discuss the latest developments related to the Company\u2019s ongoing Cancer Appetite Recovery Study (CAReS). Presentation details: Event: Artelo\u2019s Presentation at the Sequire Biotechnology Conference Date: Thursday, February 2, 2023 Time: 1:00 PM Eastern Time Register to watch the &hellip; Continue reading &quot;Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-26T13:34:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd\",\"datePublished\":\"2023-01-26T13:34:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/\"},\"wordCount\":582,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/\",\"name\":\"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\",\"datePublished\":\"2023-01-26T13:34:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/","og_locale":"en_US","og_type":"article","og_title":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk","og_description":"CEO Gregory Gorgas to discuss developments related to the Company\u2019s\u00a0 Cancer Appetite Recovery Study (CAReS) Presentation on Thursday, February 2, 2023 at 1:00 PM ET SOLANA BEACH, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) &#8212; Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, announced today that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting virtually at the Sequire Biotechnology Conference. Mr. Gorgas plans to discuss the latest developments related to the Company\u2019s ongoing Cancer Appetite Recovery Study (CAReS). Presentation details: Event: Artelo\u2019s Presentation at the Sequire Biotechnology Conference Date: Thursday, February 2, 2023 Time: 1:00 PM Eastern Time Register to watch the &hellip; Continue reading \"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-26T13:34:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd","datePublished":"2023-01-26T13:34:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/"},"wordCount":582,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/","name":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=","datePublished":"2023-01-26T13:34:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczNzI5MSM1Mzc2NTIyIzIxODc1NzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-sequire-biotechnology-conference-on-february-2nd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/726152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=726152"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/726152\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=726152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=726152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=726152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}